Hypersensitivity Pneumonitis clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Sorry, in progress, not accepting new patients

    A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants with PPF over 52 weeks.

    San Francisco, California and other locations

Our lead scientists for Hypersensitivity Pneumonitis research studies include .

Last updated: